Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchodilator properties and safety of repeated V0162 inhalation powder in asthma
2013-002517-35Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of (R)-mequitazine in asthma (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Normalized AUC0-24h of FEV1 on last day of each treatment period. Started Jul 2013; status: completed.
02
Drugs
(R)-mequitazine
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-002517-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002517-35.